- Home
- CSV vs PCRX Comparison
CSV vs PCRX Comparison
Compare CSV & PCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CSV
- PCRX
- Stock Information
- Founded
- CSV 1991
- PCRX 2006
- Country
- CSV United States
- PCRX United States
- Employees
- CSV N/A
- PCRX N/A
- Industry
- CSV Other Consumer Services
- PCRX Biotechnology: Pharmaceutical Preparations
- Sector
- CSV Consumer Discretionary
- PCRX Health Care
- Exchange
- CSV Nasdaq
- PCRX Nasdaq
- Market Cap
- CSV 634.3M
- PCRX 1.2B
- IPO Year
- CSV 1996
- PCRX 2011
- Fundamental
- Price
- CSV $46.20
- PCRX $24.02
- Analyst Decision
- CSV Strong Buy
- PCRX Buy
- Analyst Count
- CSV 2
- PCRX 9
- Target Price
- CSV $50.50
- PCRX $29.89
- AVG Volume (30 Days)
- CSV 97.7K
- PCRX 526.9K
- Earning Date
- CSV 07-30-2025
- PCRX 07-29-2025
- Dividend Yield
- CSV 0.98%
- PCRX N/A
- EPS Growth
- CSV 47.76
- PCRX N/A
- EPS
- CSV 2.99
- PCRX N/A
- Revenue
- CSV $407,774,000.00
- PCRX $702,772,000.00
- Revenue This Year
- CSV $1.96
- PCRX $7.54
- Revenue Next Year
- CSV $2.93
- PCRX $10.78
- P/E Ratio
- CSV $15.34
- PCRX N/A
- Revenue Growth
- CSV 4.42
- PCRX 3.08
- 52 Week Low
- CSV $25.84
- PCRX $11.16
- 52 Week High
- CSV $46.47
- PCRX $29.33
- Technical
- Relative Strength Index (RSI)
- CSV 64.54
- PCRX 36.83
- Support Level
- CSV $43.52
- PCRX $23.85
- Resistance Level
- CSV $44.66
- PCRX $25.16
- Average True Range (ATR)
- CSV 1.00
- PCRX 0.79
- MACD
- CSV -0.10
- PCRX -0.12
- Stochastic Oscillator
- CSV 78.00
- PCRX 8.20
About CSV Carriage Services Inc.
Carriage Services Inc is a provider of funeral and cemetery services and merchandise in the United States. It operates in two business segments: The Funeral Home Operations segment offers burial, cremation, and consultation services; removes and prepares remains; sells caskets, urns, and related funeral merchandise; and enables the use of funeral home facilities for visitation, remembrance, and transportation services. The Cemetery Operations segment provides services, such as mausoleum spaces and niches, private estates, lawn crypt gardens, traditional single burial gravesites, and burial vaults. The majority of revenue is derived from The Funeral Home Operations segment.
About PCRX Pacira BioSciences Inc.
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.